Stock market announcement archive

LIFE: Lifecare AS launching a UK subsidiary

November 8, 2022
Lifecare has incorporated a new subsidiary, Lifecare Chemistry Ltd, located inBath, UK. - This move gives us clear strategic advantages related to chemical researchdevelopment and builds on the close and good collaboration Lifecare already hasestablished with the University of Bath, says CEO Joacim Holter.Since 2020, Lifecare has worked together with researchers at the University ofBath […]
Read more

LIFE: Cancellation of subsequent offering by Lifecare AS

November 3, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more

LIFE: Key information relating to subsequent offering by Lifecare AS

October 27, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement published on 26 October2022 by […]
Read more

Lifecare AS – Transactions by closely associated parties of primary insiders

October 26, 2022
Reference is made to the stock exchange announcement by Lifecare AS (the"Company") on 26 October 2022 regarding the successful placing of a privateplacement of new shares (the "Offer Shares") with gross proceeds ofapproximately NOK 45 million (the "Private Placement"). Please see the attached form for details on transactions conducted by a closelyassociated party of a […]
Read more

Lifecare – Contemplated private placement

October 26, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCHRELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOESNOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Lifecare AS ("Lifecare" or the "Company") has retained Carnegie AS as bookrunnerand manager […]
Read more

Presentation on Nordic Life Science Congress and updated Investor Presentation – Lifecare Newsletter

October 7, 2022
Bergen, Norway 7 October 2022 Watch Lifecare's company presentation at the LSX Nordic Congress for LiceScience and Investor executives in Copenhagen, take a look at our updatedinvestor presentation and our new animation video explaining our technology. Read more in Lifecare's newsletter:https://lifecare.no/news/information-from-lifecare-october-2022/This is Lifecare Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for […]
Read more

LIFE: Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations

September 27, 2022
Conducting clinical trials on humans is a significant step towards Lifecare'sgoal of contributing to helping people with diabetes to live a normal life. The purpose of the first study is to optimize signal reading from the company'sgroundbreaking sensor technology for continuous glucose monitoring for peoplewith diabetes. The glucose sensor for the clinical trials is produced […]
Read more

Lifecare signs Letter of Intent – Production location in Mainz

September 14, 2022
Bergen, Norway 14.9.22 Lifecare AS (Lifecare) has signed a Letter of Intent (LOI) with InnovationsparkMainz GmbH & Co KG (IVP). On this basis Lifecare and IVP will initiate anintensive joint development of a new Lifecare manufacturing location in Mainz(Germany), with an optimized infrastructure for sensor-production. In additionto production, Lifecare intends to integrate and co-locate the […]
Read more

Lifecare innovations categorised by EU Innovation Radar as “Market Ready” and among top 14 % in terms of “Market Creation Potential” – Lifecare newsletter August 2022

August 8, 2022
Bergen, Norway 8 August 2022Independent experts from the European Commission's Innovation Radar havereviewed Lifecares technology in the EU funded project FORGETDIABETES. Thereview concludes that Lifecare's innovations are "Market Ready" and consideredamong the top 14% of innovations in scientific projects receiving financialgrants from the European Commission.Lifecare's involvement in the project FORGETDIABETES involves two keyinnovations: 1. Lifecare […]
Read more

Subscriptions by primary insiders and employees under Lifecare Employee Share Purchase Program – Registration of new share capital

July 26, 2022
Bergen, Norway 26.7.22Reference is made to Stock Exchange Announcement 15 July 2022 regardingsubscriptions under Lifecare Employee Share Purchase Program and the share issueresolved by Lifecare's Board of Directors. Employees in the Lifecare Group have been allocated in total 124 719 shares, ofwhich primary insiders Joacim Holter (Lifecare CEO) and Prof. Andreas Pfützner(Lifecare CSO) both have […]
Read more